- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/18 - 1,4-BenzodiazepinesHydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
Patent holdings for IPC class C07D 243/18
Total number of patents in this class: 15
10-year publication summary
|
0
|
0
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
9 |
| The Regents of the University of Michigan | 5016 |
2 |
| Enanta Pharmaceuticals, Inc. | 424 |
1 |
| Ayala Pharmaceuticals Inc. | 11 |
1 |
| Iharabras S.A. Indústrias Químicas | 16 |
1 |
| Immunome, Inc. | 1 |
1 |
| Other owners | 0 |